Latest Headlines

Latest Headlines

Icagen shares plunge on failed asthma trial

Icagen's share price was battered this morning after the develop announced that it is shelving its experimental asthma drug, senicapoc, after it failed a mid-stage trial. Icagen shares plunged 42

Icagen boosted by upbeat mid-stage results for asthma

Shares of Research Triangle Park, NC-based Icagen were buoyed this morning on the news that its experimental allergic asthma therapy proved promising in a mid-stage trial. Researchers for the